Literature DB >> 10717329

Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.

C Mendoza1, H Sato, K Hiyama, S Ishioka, T Isobe, H Maeda, E Hiyama, K Inai, M Yamakido.   

Abstract

L-myc S-allele was reported to be associated with metastasis of lung cancer, indicating the existence of a putative tumor suppressor gene around the L-myc locus, in linkage disequilibrium. The relationship between the S-allele and inactivation of some tumor suppressor gene should be indicated by allelic loss. Therefore, we examined the association between the L-myc S-allele and loss of heterozygosity at 11 loci around the L-myc locus (1p34.3) in primary lesions or other biological characteristics in lung cancer. No associations between the S-allele and allelic loss around the L-myc locus or other characteristics were found. According to the deletion map, three shortest regions of overlap between D1S230 and D1S76 were identified. While loss of heterozygosity at SRO1, between D1S2797 and MYCL1, showed no relationship with the pathological stage, it was more frequently observed in squamous cell carcinoma than adenocarcinoma (P=0.019), and associated with high telomerase activity (P=0.046), an indicator of cellular immortality. In conclusion, we found three shortest regions of overlap (SROs) from D1S2797 to pter, and a tumor suppressor gene, which might be associated with suppression of lung cancer development but not with L-myc S-allele, may exist in SRO1.

Entities:  

Mesh:

Year:  2000        PMID: 10717329     DOI: 10.1016/s0169-5002(99)00125-7

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  1 in total

1.  The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

Authors:  Andika C Putra; Hidetaka Eguchi; Kian Leong Lee; Yuko Yamane; Ewita Gustine; Takeshi Isobe; Masahiko Nishiyama; Keiko Hiyama; Lorenz Poellinger; Keiji Tanimoto
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.